South San Francisco, CA, November 18, 2024 – FlemingMartin is pleased to announce that Cytokinetics (NASDAQ: CYTK), a late clinical stage biopharmaceutical company dedicated to discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors, has hired Kirstin Arnold to be their new Head of Total Rewards.
Kirstin possesses two decades of compensation and benefits leadership experience, spanning roles in the life sciences industry, technology sector, retail business, and the consulting world. Her past companies range from ascending startups to multi-billion-dollar corporations, and include CARGO Therapeutics, Spur Therapeutics, Global Blood Therapeutics, Salesforce, Juniper Networks, Williams-Sonoma, and Mercer Consulting. She is passionate about designing competitive global compensation and benefits strategies, and she is familiar with scaling up the total rewards function to support aggressive business expansion. Kirstin earned her bachelor’s degree in Organization & HR Management from the University of British Columbia.
